KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Current Taxes (2018 - 2025)

Ionis Pharmaceuticals has reported Current Taxes over the past 10 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Current Taxes at $2.7 million for Q4 2025, up 7879.41% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (up 7879.41% YoY), and the annual figure for FY2025 was $2.7 million, up 7879.41%.
  • Current Taxes for Q4 2025 was $2.7 million at Ionis Pharmaceuticals, up from $101000.0 in the prior quarter.
  • Over the last five years, Current Taxes for IONS hit a ceiling of $31.1 million in Q3 2023 and a floor of $14000.0 in Q2 2022.
  • Median Current Taxes over the past 5 years was $675500.0 (2021), compared with a mean of $4.6 million.
  • Biggest five-year swings in Current Taxes: soared 194087.5% in 2023 and later crashed 99.87% in 2024.
  • Ionis Pharmaceuticals' Current Taxes stood at $36000.0 in 2021, then skyrocketed by 17258.33% to $6.2 million in 2022, then tumbled by 65.58% to $2.2 million in 2023, then tumbled by 98.42% to $34000.0 in 2024, then soared by 7879.41% to $2.7 million in 2025.
  • The last three reported values for Current Taxes were $2.7 million (Q4 2025), $101000.0 (Q3 2025), and $81000.0 (Q2 2025) per Business Quant data.